Byron J. Hoogwerf, MD

Article

In reply: Intensive therapy of type 2 diabetes (ACCORD trial)

Author:: Byron J. Hoogwerf, MD

Publish date: February 1, 2009

Article

Does intensive therapy of type 2 diabetes help or harm? Seeking accord on ACCORD

Author:: Byron J. Hoogwerf, MD

Publish date: October 1, 2008

Even though more people died in the intensive-treatment group than in the standard-treatment group, the results from this trial should not substant...

Article

Exenatide and pramlintide: New glucose-lowering agents for treating diabetes mellitus

Author:: Byron J. Hoogwerf, MD

Publish date: May 1, 2006

Insulin is not the only hormone that regulates plasma glucose levels. Two new drugs based on native hormones became available in 2005.

Article

Perioperative management of diabetes mellitus: How should we act on the limited evidence?

Author:: Byron J. Hoogwerf, MD

Publish date: March 1, 2006

Article

Cholesterol guidelines update: More aggressive therapy for higher-risk patients

Author:: Byron J. Hoogwerf, MD

Publish date: March 1, 2005

As new evidence comes in, guidelines for treating elevated cholesterol keep getting more aggressive—and more complicated. The 2001 guidelines were ...

Article

A DASH-like diet can decrease cardiovascular risk, but barriers to implementation exist

Author:: Byron J. Hoogwerf, MD

Publish date: September 1, 2004

Making dietary changes and sticking to them is necessary but difficult.

Article

A truly deadly quartet: Obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia

Author:: Byron J. Hoogwerf, MD

Publish date: December 1, 2002

The best available treatment is to control one's weight, exercise regularly, stop smoking, and eat a healthy diet.

Article

Pancreas transplantation in type 1 diabetes: Hope vs reality

Author:: Byron J. Hoogwerf, MD

Publish date: April 1, 2000

Freedom from insulin injections, but at the price of lifelong immunosuppression.

Article

Ramipril lowered cardiovascular risk, but vitamin E did not

Author:: Byron J. Hoogwerf, MD

Publish date: April 1, 2000

In this landmark trial, ACE inhibitors showed benefit beyond lowering blood pressure.

Article

Should all diabetic patients take ACE inhibitors, even those without proteinuria?

Author:: Byron J. Hoogwerf, MD

Publish date: April 1, 1999

To give ACE inhibitors to all diabetic patients would be premature, but these agents have clear indications in some patients.

Article

Effects of glucose and blood pressure control on complications of type 2 diabetes mellitus

Author:: Byron J. Hoogwerf, MD

Publish date: April 1, 1999

A 20-year study shows that intensive blood glucose control is beneficial in type 2 diabetes.

Article

Two patients with neuroglycopenia

Author:: Byron J. Hoogwerf, MD

Publish date: February 1, 1998

One patient suffers from periodic "silliness," the other suffers from syncope. What is the diagnosis and treatment?

Article

In reply: The protein-sparing modified fast for obesity-related medical problems

Author:: Byron J. Hoogwerf, MD

Publish date: August 1, 1997

Article

Lipid-lowering therapy after coronary artery bypass surgery: The Post-CABG trial

Author:: Byron J. Hoogwerf, MD

Publish date: July 1, 1997

The Post-CABG trial is an important milestone that demonstrates the benefits of treating hypercholesterolemia in patients who have had bypass surge...

Article

The protein-sparing modified fast for obesity-related medical problems

Author:: Byron J. Hoogwerf, MD

Publish date: May 1, 1997

This ketogenic diet of 800 calories per day is useful for carefully selected patients.